. . . . . . . "[This study identified apomorphine use and levodopa dosages between 500 and 1000 mg as non-genetic and the 15A DRD2 CA repeat allele as genetic determinants for the discontinuation of non-ergoline DA treatment in patients with PD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-21"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:05+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .